Nadolol



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 25.0%
Migraine 18.2%
Blood Pressure Increased 12.5%
Arrhythmia 6.8%
Long Qt Syndrome 6.8%
Ventricular Tachycardia 4.5%
Heart Rate Increased 3.4%
Blood Pressure 2.3%
Hypothyroidism 2.3%
Insomnia 2.3%
Mitral Valve Prolapse 2.3%
Portal Hypertension 2.3%
Syncope 2.3%
Tachycardia 2.3%
Angina Pectoris 1.1%
Antiplatelet Therapy 1.1%
Atrial Fibrillation 1.1%
Blood Pressure Abnormal 1.1%
Cardiac Murmur 1.1%
Diabetes Mellitus 1.1%
Hypoglycaemic Unconsciousness 13.5%
Urticaria 7.7%
Completed Suicide 5.8%
Dysuria 5.8%
Left Ventricular Dysfunction 5.8%
Malaise 5.8%
Product Quality Issue 5.8%
Convulsion 3.8%
Drug Ineffective 3.8%
Drug Intolerance 3.8%
Feeling Abnormal 3.8%
Glossodynia 3.8%
Heart Rate Increased 3.8%
Hypoglycaemia 3.8%
Hypoglycaemic Seizure 3.8%
Hypotension 3.8%
Palpitations 3.8%
Product Substitution Issue 3.8%
Sinus Arrest 3.8%
Syncope 3.8%
Secondary
Product Used For Unknown Indication 35.8%
Hypertension 12.6%
Atrial Fibrillation 6.3%
Drug Use For Unknown Indication 5.7%
Blood Pressure Increased 4.4%
Atrial Tachycardia 3.8%
Heart Rate Increased 3.8%
Portal Hypertension 3.1%
Suicide Attempt 3.1%
Cardiac Disorder 2.5%
Essential Tremor 2.5%
Non-small Cell Lung Cancer 2.5%
Bipolar Disorder 1.9%
Crohn's Disease 1.9%
General Anaesthesia 1.9%
Migraine 1.9%
Nodal Arrhythmia 1.9%
Retroperitoneal Fibrosis 1.9%
Agitation 1.3%
Anaesthesia Reversal 1.3%
Completed Suicide 11.4%
Dizziness 11.4%
Vomiting 9.1%
Cardio-respiratory Arrest 4.5%
Drug Ineffective 4.5%
Extrasystoles 4.5%
Gastrointestinal Haemorrhage 4.5%
Large Intestine Polyp 4.5%
Loss Of Consciousness 4.5%
Neuralgia 4.5%
Palpitations 4.5%
Reaction To Drug Excipients 4.5%
Renal Tubular Necrosis 4.5%
Respiratory Arrest 4.5%
Sinus Arrest 4.5%
Toxicity To Various Agents 4.5%
Abnormal Dreams 2.3%
Agitation 2.3%
Bradycardia 2.3%
Cardiac Failure Acute 2.3%
Concomitant
Product Used For Unknown Indication 25.3%
Hypertension 10.8%
Drug Use For Unknown Indication 10.1%
Hepatitis C 9.2%
Depression 4.7%
Gastrooesophageal Reflux Disease 4.3%
Migraine 3.9%
Pain 3.9%
Prophylaxis 3.8%
Blood Cholesterol Increased 3.3%
Diabetes Mellitus 2.9%
Rheumatoid Arthritis 2.8%
Hepatic Neoplasm Malignant 2.4%
Anxiety 2.3%
Atrial Fibrillation 2.2%
Insomnia 1.8%
Headache 1.7%
Multiple Sclerosis 1.6%
Type 2 Diabetes Mellitus 1.5%
Osteoporosis 1.5%
Weight Increased 11.1%
Vomiting 10.0%
Nausea 7.7%
Weight Decreased 6.6%
Varices Oesophageal 5.5%
Drug Ineffective 5.3%
White Blood Cell Count Decreased 4.9%
Dyspnoea 4.4%
Fatigue 4.4%
Flushing 4.4%
Headache 4.4%
Urinary Tract Infection 4.0%
Somnolence 3.8%
Wheezing 3.8%
Pyrexia 3.5%
Diarrhoea 3.3%
Thyroid Disorder 3.3%
Wrong Technique In Drug Usage Process 3.3%
Pain 3.1%
Pain In Extremity 3.1%
Interacting
Product Used For Unknown Indication 30.0%
Blood Cholesterol Increased 15.0%
Smoking Cessation Therapy 15.0%
Wolff-parkinson-white Syndrome 15.0%
Dyspnoea 10.0%
Off Label Use 5.0%
Stress Echocardiogram 5.0%
Syncope 5.0%
Drug Interaction 50.0%
Cardiac Flutter 16.7%
Extrasystoles 16.7%
Traumatic Intracranial Haemorrhage 16.7%